Serroflo will substantially improve the affordability of fixed combinations in Europe and help manage health costs for respiratory treatment, the company said.
Last few months saw some high profile changes in the managements of Indian pharma companies. Entirely promoter-controlled companies giving way to professional managements brought in from top multinationals to drive global ambitions, reports CNBC-TV18's Archana Shukla.